BLCO
Bausch + Lomb·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 3
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BLCO
Bausch + Lomb Corporation
A leading global eye health company that develops, manufactures and sells optical products
Healthcare Equipment and Supplies
08/19/2020
05/06/2022
New York Stock Exchange
13,500
12-31
Common stock
520 Applewood Crescent, Vaughan, Ontario, Canada L4K 4B4
--
Bausch + Lomb Corporation was incorporated in Canada on August 19, 2020. They are a leading global eye care company dedicated to protecting and enhancing the vision of millions of people around the world — from the moment of birth to every stage of life. With a comprehensive portfolio of more than 400 products, they aim to provide their customers with the full range of eye health needs throughout their lives. Their iconic brand is built on the deep trust and loyalty of their customers built over their nearly 170 years of history.
Earnings Call
Company Financials
EPS
BLCO has released its 2025 Q3 earnings. EPS was reported at 0.18, versus the expected 0.16, beating expectations. The chart below visualizes how BLCO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BLCO has released its 2025 Q3 earnings report, with revenue of 1.28B, reflecting a YoY change of 7.11%, and net profit of -25.00M, showing a YoY change of -412.50%. The Sankey diagram below clearly presents BLCO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



